Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Homogeneous Assay Measures Small Dense LDL Cholesterol

By LabMedica International staff writers
Posted on 29 Dec 2010
A simple homogeneous assay has been developed to measure plasma concentrations of small dense-low density lipoprotein (SD-LDL). More...


A rapid assay suitable for autoanalyzers has been devised to measure the concentration of SD-LDL cholesterol in blood samples and is much easier to use than the complex methods that require special equipment and long assay times.

Scientists at the Showa University School of Medicine, (Tokyo, Japan), have identified suitable surfactants and phospholipases by screening for those selective for the SD-LDL fraction (density range: 1.044 kg/L - 1.063 kg/L) and for the dissociation of other lipoproteins, including large buoyant LDL (lb-LDL). They compared this technique with ultracentrifugal isolation of LDL subfractions and with heparin-magnesium precipitation assay for SD-LDL. They measured SD-LDL-C concentrations in 460 healthy, normolipidemic individuals. Small, dense LDL is a type of LDL cholesterol that is considered to be an emerging risk factor for cardiovascular disease. It is smaller and heavier than typical LDL cholesterol and can increase the risk of developing atherosclerosis.

The homogeneous method correlated excellently with ultracentrifugation for SD-LDL-C and exhibited within-run precision. The distribution of SD-LDL-C was skewed, and the central 95% of SD-LDL-C concentrations ranged from 0.24 to 0.88 mmol/L (9.4–34.0 mg/dL). The homogeneous assay SD-LDL-C results for 60 samples from healthy volunteers were compared with those obtained by ultracentrifugation. Serum samples were obtained from these individuals who had variable serum lipid levels; LDL-C range: 1.6–5.2 mmol/L (63–199 mg/dL); triglycerides range: 0.3–5.2 mmol/L (30–472 mg/dL), and high-density lipoprotein cholesterol: 0.9–2.5 mmol/L (35–97 mg/dL).

The authors concluded that the homogeneous assay allows reproducible measurement of SD-LDL-C within 10 minutes and appears promising in further investigations of the clinical significance of SD-LDL-C. The study was published in December 2010, in Clinical Chemistry.

Related Links:

Showa University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.